Ondansetron Dosing for a 12-Year-Old, 54 kg Patient
For a 12-year-old patient weighing 54 kg, the recommended dose of ondansetron is 8 mg orally every 8 hours, which is the standard adult dosing regimen for this age and weight. 1
Dosing Rationale
Pediatric patients aged 12 years and older should receive adult dosing of ondansetron. The FDA label specifically states that in pediatric trials, response rates to ondansetron 8 mg three times daily in patients 12 to 18 years were similar to adult responses, and that "prevention of emesis in these pediatric patients was essentially the same as for adults." 1
Standard Dosing Regimens by Clinical Context
For chemotherapy-induced nausea/vomiting:
- Day 1: 16-24 mg PO as a single dose OR 8 mg PO every 8 hours 2
- Days 2-3: 8 mg PO twice daily (every 12 hours) 2
- Maximum daily dose should not exceed 32 mg 1
For general nausea/vomiting (non-chemotherapy):
- 8 mg PO every 8 hours as needed 3
- For persistent nausea, switch from PRN to scheduled around-the-clock dosing 3
For radiation-induced nausea:
- 8 mg PO 2-3 times daily 2
For postoperative nausea/vomiting:
- 16 mg PO as a single dose given 1 hour before anesthesia 1
Important Clinical Considerations
Weight-based dosing is NOT necessary for this patient. While younger pediatric patients (under 12 years) may receive weight-based dosing (0.15 mg/kg), a 12-year-old at 54 kg falls into the adult dosing category. 1
The 8 mg three times daily regimen is no longer recommended for moderately emetogenic chemotherapy due to lack of additional benefit over twice-daily dosing. 1 Studies showed that 8 mg twice daily was equally effective as 8 mg three times daily, with 61% vs 58% achieving zero emetic episodes respectively. 1
Common Pitfalls to Avoid
- Do not underdose: Avoid using pediatric dosing (4 mg) for a 12-year-old, as this age group requires adult dosing 1
- Monitor for constipation: Ondansetron commonly causes constipation, which can paradoxically worsen nausea if not addressed 3
- Maximum daily dose: Never exceed 32 mg per day due to cardiac safety concerns 1
- Repeat dosing limitations: If prophylactic ondansetron fails, administering additional doses may not provide additional benefit 4
When to Escalate Therapy
If ondansetron alone is insufficient: